[Surgical treatment of multidrug-resistant tuberculosis].

Yuji Shiraishi
Author Information
  1. Yuji Shiraishi: Section of Chest Surgery, Fukujuji Hospital, JATA, 3-1-24, Matsuyama, Kiyose-shi, Tokyo 204-8522, Japan. yujishi@mvb.biglobe.ne.jp

Abstract

Although the results of medical treatment for multidrug-resistant tuberculosis (MDR-TB) has improved, adjuvant surgical treatment remains achieving better outcomes for MDR-TB patients. We have performed pulmonary resection for MDR-TB patients aggressively. Indications for surgery include (1) persistent positive sputum despite state-of-the-art chemotherapy and (2) a high risk of relapse. For 56 patients undergoing 61 pulmonary resections for MDR-TB between January 2000 and June 2007 at our institution, the overall cure rate was 98%. An aggressive treatment approach to MDR-TB continues to be justified until a panacea for this refractory disease is available.

MeSH Term

Humans
Tuberculosis, Multidrug-Resistant

Word Cloud

Created with Highcharts 10.0.0MDR-TBtreatmentpatientsmultidrug-resistantpulmonaryAlthoughresultsmedicaltuberculosisimprovedadjuvantsurgicalremainsachievingbetteroutcomesperformedresectionaggressivelyIndicationssurgeryinclude1persistentpositivesputumdespitestate-of-the-artchemotherapy2highriskrelapse56undergoing61resectionsJanuary2000June2007institutionoverallcurerate98%aggressiveapproachcontinuesjustifiedpanacearefractorydiseaseavailable[Surgicaltuberculosis]

Similar Articles

Cited By